XML 66 R27.htm IDEA: XBRL DOCUMENT v3.19.3
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 28, 2019
Share-based Payment Arrangement [Abstract]  
NonVested Restricted Common Stock
 
Shares
 
Weighted
Average
Grant
Fair
Value
Balance, December 29, 2018
2,213,249

 
$
2.51

Granted
150,000

 
1.19

Forfeited
(275,625
)
 
2.95

Vested
(70,000
)
 
3.32

Balance, September 28, 2019
2,017,624

 
$
2.33


Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions The value of restricted stock grants that vest based on market conditions is computed on the date of grant using the Monte Carlo model with the following assumptions:
 
For the three months ended September 28, 2019
Performance price target
$
5.25

 
$
6.00

 
$
7.00

Expected volatility
48.3
%
 
48.3
%
 
48.3
%
Interest rate
1.97
%
 
1.97
%
 
1.97
%
Expected life (years)
3

 
3

 
3

Dividend yield
%
 
%
 
%

Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the nine months ended September 28, 2019 and September 29, 2018 (no tax benefits were recognized):
 
Three Months Ended
 
Nine Months Ended
 
September 28, 2019
 
September 29, 2018
 
September 28, 2019
 
September 29, 2018
Cost of product revenues
$
18,309

 
$
52,368

 
$
82,524

 
$
318,519

Research and development
73,939

 
159,436

 
262,454

 
627,519

Selling, general and administrative
359,435

 
979,026

 
1,461,021

 
2,932,581

Total
$
451,683

 
$
1,190,830

 
$
1,805,999

 
$
3,878,619

Unr